271 related articles for article (PubMed ID: 17100558)
1. New generation of liposomal drugs for cancer.
Minko T; Pakunlu RI; Wang Y; Khandare JJ; Saad M
Anticancer Agents Med Chem; 2006 Nov; 6(6):537-52. PubMed ID: 17100558
[TBL] [Abstract][Full Text] [Related]
2. Molecular targeting of drug delivery systems to cancer.
Minko T; Dharap SS; Pakunlu RI; Wang Y
Curr Drug Targets; 2004 May; 5(4):389-406. PubMed ID: 15134222
[TBL] [Abstract][Full Text] [Related]
3. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
Oku N
Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer.
Allen TM; Cheng WW; Hare JI; Laginha KM
Anticancer Agents Med Chem; 2006 Nov; 6(6):513-23. PubMed ID: 17100556
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Development of liposomal anticancer drugs.
Hyodo K; Yamamoto E; Suzuki T; Kikuchi H; Asano M; Ishihara H
Biol Pharm Bull; 2013; 36(5):703-7. PubMed ID: 23649329
[TBL] [Abstract][Full Text] [Related]
7. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy.
Dharap SS; Chandna P; Wang Y; Khandare JJ; Qiu B; Stein S; Minko T
J Pharmacol Exp Ther; 2006 Mar; 316(3):992-8. PubMed ID: 16291730
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modelling of liposomal drug release to tumour.
Chakravarty K; Dalal DC
Math Biosci; 2018 Dec; 306():82-96. PubMed ID: 30391313
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.
Dharap SS; Wang Y; Chandna P; Khandare JJ; Qiu B; Gunaseelan S; Sinko PJ; Stein S; Farmanfarmaian A; Minko T
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12962-7. PubMed ID: 16123131
[TBL] [Abstract][Full Text] [Related]
10. Liposomal nanomedicines in the treatment of prostate cancer.
Kroon J; Metselaar JM; Storm G; van der Pluijm G
Cancer Treat Rev; 2014 May; 40(4):578-84. PubMed ID: 24216226
[TBL] [Abstract][Full Text] [Related]
11. The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
Krishna R; Mayer LD
Anticancer Res; 1999; 19(4B):2885-91. PubMed ID: 10652569
[TBL] [Abstract][Full Text] [Related]
12. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
Andresen TL; Jensen SS; Jørgensen K
Prog Lipid Res; 2005 Jan; 44(1):68-97. PubMed ID: 15748655
[TBL] [Abstract][Full Text] [Related]
13. [Elucidation for Intratumor Localization of a DDS-based Anticancer Drug and Enhancement of Its Therapeutic Effects via Improvement of the Tumor Microenvironment].
Ando H
Yakugaku Zasshi; 2021; 141(11):1241-1245. PubMed ID: 34719544
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
Abu Lila AS; Ishida T; Kiwada H
Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
[TBL] [Abstract][Full Text] [Related]
15. Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2.
Andresen TL; Jensen SS; Kaasgaard T; Jørgensen K
Curr Drug Deliv; 2005 Oct; 2(4):353-62. PubMed ID: 16305438
[TBL] [Abstract][Full Text] [Related]
16. The role for liposomal drug delivery in molecular and pharmacological strategies to overcome multidrug resistance.
Mayer LD; Shabbits JA
Cancer Metastasis Rev; 2001; 20(1-2):87-93. PubMed ID: 11831652
[TBL] [Abstract][Full Text] [Related]
17. [Development of a Novel Liposomal DDS by Manipulating Pharmacokinetics and Intracellular Trafficking for Drug Therapy and Nucleic Acid Medicine].
Hatakeyama H
Yakugaku Zasshi; 2018; 138(5):591-598. PubMed ID: 29709998
[TBL] [Abstract][Full Text] [Related]
18. Second generation liposomal cancer therapeutics: transition from laboratory to clinic.
Sen K; Mandal M
Int J Pharm; 2013 May; 448(1):28-43. PubMed ID: 23500602
[TBL] [Abstract][Full Text] [Related]
19. Safety of novel liposomal drugs for cancer treatment: Advances and prospects.
He K; Tang M
Chem Biol Interact; 2018 Nov; 295():13-19. PubMed ID: 28919304
[TBL] [Abstract][Full Text] [Related]
20. Updates on the use of liposomes for active tumor targeting in cancer therapy.
Yan W; Leung SS; To KK
Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
